Literature DB >> 18032622

Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing.

Adam Baldwin1, Eshwar Mahenthiralingam, Pavel Drevinek, Chris Pope, David J Waine, Deborah A Henry, David P Speert, Phil Carter, Peter Vandamme, John J LiPuma, Chris G Dowson.   

Abstract

Burkholderia multivorans is a prominent B. cepacia complex (BCC) species causing infection in people with cystic fibrosis. Despite infection control measures being introduced to reduce the spread of BCC there is a continued emergence of infections by B. multivorans. Our objective was to analyze a global collection of B. multivorans isolates, comparing those from environmental and clinical sources with those from reported outbreaks. Multilocus sequence typing (MLST) was performed on 107 B. multivorans isolates to provide a detailed analysis of the global population biology of this species. MLST resolved 64 B. multivorans sequence types. Twelve of these were globally distributed and associated with human infection; two of these (ST-21 and ST-375) were also composed of environmental isolates. These global lineages included strains previously linked to large outbreaks (e.g., French epidemic clone ST-16). Though few environmental isolates of B. multivorans were available for analysis, of six strains identified, three were identical to strains recovered from cystic fibrosis (CF) infection. Although the ability of B. multivorans to cause CF outbreaks is known, our report here concerning the existence of globally distributed B. multivorans CF strains is a new observation for this emerging B. cepacia complex pathogen and suggests that certain strain types may be better adapted to human infection than others. Common transmission-associated risk factors were not obviously linked to the globally distributed strains; however, the overlap in strains recovered from water environments, industrial products, and human infection suggests that environmental sources may be an important reservoir for infection with B. multivorans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032622      PMCID: PMC2224285          DOI: 10.1128/JCM.01818-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Authors:  E Mahenthiralingam; T Coenye; J W Chung; D P Speert; J R Govan; P Taylor; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis.

Authors:  J J LiPuma; T Spilker; L H Gill; P W Campbell; L Liu; E Mahenthiralingam
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

4.  Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis.

Authors:  J S Chen; K A Witzmann; T Spilker; R J Fink; J J LiPuma
Journal:  J Pediatr       Date:  2001-11       Impact factor: 4.406

5.  Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation.

Authors:  David G Heath; Kathy Hohneker; Charlene Carriker; Kelly Smith; Jonathan Routh; John J LiPuma; Robert M Aris; David Weber; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

6.  Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.

Authors:  E Mahenthiralingam; P Vandamme; M E Campbell; D A Henry; A M Gravelle; L T Wong; A G Davidson; P G Wilcox; B Nakielna; D P Speert
Journal:  Clin Infect Dis       Date:  2001-10-04       Impact factor: 9.079

Review 7.  Burkholderia cepacia complex infection in patients with cystic fibrosis.

Authors:  Eshwar Mahenthiralingam; Adam Baldwin; Peter Vandamme
Journal:  J Med Microbiol       Date:  2002-07       Impact factor: 2.472

8.  An epidemic Burkholderia cepacia complex strain identified in soil.

Authors:  John J LiPuma; Theodore Spilker; Tom Coenye; Carlos F Gonzalez
Journal:  Lancet       Date:  2002-06-08       Impact factor: 79.321

Review 9.  Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.

Authors:  John R W Govan; Alan R Brown; Andrew M Jones
Journal:  Future Microbiol       Date:  2007-04       Impact factor: 3.165

10.  Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.

Authors:  David P Speert; Maureen E Campbell; Deborah A Henry; Ruth Milner; Fatma Taha; Anna Gravelle; A George F Davidson; Lawrence T K Wong; Eshwar Mahenthiralingam
Journal:  Am J Respir Crit Care Med       Date:  2002-10-01       Impact factor: 21.405

View more
  21 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Global distribution and evolution of a toxinogenic Burkholderia-Rhizopus symbiosis.

Authors:  Gerald Lackner; Nadine Möbius; Kirstin Scherlach; Laila P Partida-Martinez; Robert Winkler; Imke Schmitt; Christian Hertweck
Journal:  Appl Environ Microbiol       Date:  2009-03-13       Impact factor: 4.792

3.  Biocide susceptibility of the Burkholderia cepacia complex.

Authors:  Helen Rose; Adam Baldwin; Christopher G Dowson; Eshwar Mahenthiralingam
Journal:  J Antimicrob Chemother       Date:  2009-01-18       Impact factor: 5.790

4.  Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine.

Authors:  P E Makidon; J Knowlton; J V Groom; L P Blanco; J J LiPuma; A U Bielinska; J R Baker
Journal:  Med Microbiol Immunol       Date:  2009-12-06       Impact factor: 3.402

5.  Linocin and OmpW Are Involved in Attachment of the Cystic Fibrosis-Associated Pathogen Burkholderia cepacia Complex to Lung Epithelial Cells and Protect Mice against Infection.

Authors:  Siobhán McClean; Marc E Healy; Cassandra Collins; Stephen Carberry; Luke O'Shaughnessy; Ruth Dennehy; Áine Adams; Helen Kennelly; Jennifer M Corbett; Fiona Carty; Laura A Cahill; Máire Callaghan; Karen English; Bernard P Mahon; Sean Doyle; Minu Shinoy
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

6.  Diversity analysis of Burkholderia cepacia complex in the water bodies of West Lake, Hangzhou, China.

Authors:  Yuan Fang; Guan-Lin Xie; Miao-Miao Lou; Bin Li; Ibrahim Muhammad
Journal:  J Microbiol       Date:  2011-05-03       Impact factor: 3.422

7.  Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases.

Authors:  José J Degrossi; Cindy Merino; Adela M Isasmendi; Lorena M Ibarra; Chelsea Collins; Nicolás E Bo; Mariana Papalia; Jennifer S Fernandez; Claudia M Hernandez; Krisztina M Papp-Wallace; Robert A Bonomo; Miryam S Vazquez; Pablo Power; María S Ramirez
Journal:  Curr Microbiol       Date:  2019-02-19       Impact factor: 2.188

8.  Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of Burkholderia cenocepacia and application to nationwide epidemiological analysis.

Authors:  Christine Segonds; Michelle Thouverez; Antoine Barthe; Nadège Bossuet-Greif; Lenka Tisseyre; Patrick Plésiat; Gilles Vergnaud; Gérard Chabanon; Christine Pourcel
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

9.  Expanded multilocus sequence typing for burkholderia species.

Authors:  Theodore Spilker; Adam Baldwin; Amy Bumford; Chris G Dowson; Eshwar Mahenthiralingam; John J LiPuma
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

10.  Susceptibility of Caenorhabditis elegans to Burkholderia infection depends on prior diet and secreted bacterial attractants.

Authors:  Vaughn S Cooper; Wendy A Carlson; John J Lipuma
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.